Atlas Trials

Non-eligible for Autologous Stem Cell Transplantation (ASCT)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-eligible for Autologous Stem Cell Transplantation (ASCT)

RecordFirmDate
Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT (NCT05218603)PETHEMA Foundation2021-11-30

Track Non-eligible for Autologous Stem Cell Transplantation (ASCT) automatically

Every clearance here is in the API, with alerts when new ones post.